BIMI Holdings (STU:63N) Research & Development : €0.00 Mil (TTM As of Sep. 2023)

View and export this data going back to . Start your Free Trial

What is BIMI Holdings Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. BIMI Holdings's Research & Development for the three months ended in Sep. 2023 was €0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2023 was €0.00 Mil.

BIMI Holdings Research & Development Historical Data

The historical data trend for BIMI Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BIMI Holdings Research & Development Chart

BIMI Holdings Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Research & Development

Get a 7-Day Free Trial

BIMI Holdings Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Research & Development	Get a 7-Day Free Trial															-	-	-	-	-

BIMI Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

BIMI Holdings (STU:63N) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

BIMI Holdings Research & Development Related Terms

Thank you for viewing the detailed overview of BIMI Holdings's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

BIMI Holdings (STU:63N) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » BIMI Holdings Inc (STU:63N) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

BIMI:USA

Address

Chongqing Corporation Avenue, 9th Floor, Building 2, Yuzhong District, Chongqing, CHN, 400010

Website

https://www.usbimi.com

BIMI International Medical Inc is a healthcare product and provider, offering a broad range of healthcare products and related services and operates private hospitals in China. The company is engaged in four business segments, Pharmaceuticals wholesale, Medical devices wholesale, Medical services, and Pharmacy retail. It generates maximum revenue from the pharmaceuticals wholesale segment. It mainly sources its products from large state-owned pharmaceutical manufacturers and wholesalers and mid-sized or small private pharmaceutical manufacturers and wholesalers. The Company's revenues were generated in the PRC.

BIMI Holdings (STU:63N) Headlines

No Headlines